"I was listening to a podcast where a woman talked about her experience of living with two uteruses. And I was like ‘d*mn, ...

A blood-based test with five biomarkers shows high accuracy in distinguishing patients with early-stage pancreatic cancer ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

Galleri should have a good chance to win FDA marketing approval in early 2027. But insurance coverage and widespread adoption ...

The refusal of blood transfusions by Jehovah’s Witnesses poses a major challenge in treating acute myeloid leukaemia (AML), ...

The US Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a patient’s memory problems are likely caused by Alzheimer’s disease. HealthDay News — ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease. The new test, called ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...

People who develop rheumatoid arthritis experience changes to their immune systems long before their joints become swollen and painful, suggesting that early treatment might stop or limit damage, a ...

Scientists at the University of East Anglia and Oxford Biodynamics have developed a high accuracy blood test to diagnose chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME/CFS). The ...

Iberdomide, combined with Darzalex and dexamethasone, improves MRD negativity in relapsed multiple myeloma, showcasing CELMoDs' potential in treatment. Early-stage blood cancer diagnosis and ...